SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹117 Cr | ₹87 Cr | ₹78 Cr | ₹75 Cr | ₹35 Cr |
What is the latest Total Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹117 Cr |
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹78 Cr |
| Mar2023 | ₹75 Cr |
| Mar2022 | ₹35 Cr |
How is Total Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹117 Cr | 35.31 | |
| Mar2025 | ₹87 Cr | 11.48 | |
| Mar2024 | ₹78 Cr | 3.83 | |
| Mar2023 | ₹75 Cr | 113.50 | |
| Mar2022 | ₹35 Cr | - | |
Compare Total Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹3,316.5 Cr | 9.9% | 24.1% | 86.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 9.9% |
24.1% |
86.2% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses